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1. Introduction 
Natural killer (NK) cells are a heterogeneous multifunctional population of immune cells 
traditionally classified as cytotoxic lymphocytes of the innate immune system [1]. NK cells 
possess several key characteristics of innate immune cells. They are capable of rapid effector 
response without prior sensitization and express a range of germline-encoded receptors that 
do not need any additional rearrangement. On the other hand NK cells share some 
phenotypic and functional characteristics with cytotoxic T cells: they express common 
surface markers (CD2, CD7, CD8), recognize infected and tumor-transformed cells of host 
organism and also mediate the similar mechanism of granule-dependent cytolysis. NK cells 
are able to interact with major histocompatibility complex class I (MHC-I) self-molecules as 
distinct from other innate immune cells. Moreover, recent findings show that NK cells 
possess a form of immunological memory [2]. Thus, NK cells represent evolutionary and 
functional link connecting innate and adaptive immunity. 
In the organism NK cells fulfill two main functions: they provide constitutive cytotoxic 
activity against infected, malignant and other damaged cells and regulate innate and 
adaptive immune reactions by production of chemokines and cytokines. At early stage of 
immune response NK cells are the main sources of IFN-γ, triggering the adaptive immune 
response [3]. NK cells interact with other cells of immune system, participating in contact-
dependent costimulation. Primed dendritic cells (DCs) and macrophages produce a range of 
cytokines including IL-12, IL-15 and IL-18 which activate NK cells. Contact interaction of 
NK cells with these cells also induces macrophage and DC maturation [4, 5]. NK cells 
express receptors for many cytokines and chemokines and therefore might be influenced by 
other cells producing them [6].  
NK cells are classically identified in humans as lineage-negative CD3–CD14–CD19–CD56+ 
leukocytes circulating in peripheral blood and residing in various organs and tissues of the 
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body. Two main subpopulations of NK cells based on the expression levels of CD16 and 
CD56 have been described [7]. Subpopulation CD56dimCD16+ is prevalent in peripheral 
blood. These cells express receptors of killer-cell immunoglobulin-like receptor (KIR) family 
and possess high levels of cytotoxic activity. Because they express CD16 (FcγRIII), CD56dim 
NK cells are able to recognize and lyze cells opsonized with IgG antibodies [8, 9]. 
CD56brightCD16– NK cells consist of approximately 5-10% of peripheral blood NK cells; they 
reside mostly in secondary lymphoid organs, liver and uterus. CD56bright cells express CCR7 
and CD62L (L-selectin) which allow them to migrate to the lymph nodes. They are 
considered to be a regulatory NK cell subpopulation because they are able to contact with 
DCs, have low cytotoxicity and high levels of cytokine production compared with CD56dim 
cells. Due to constitutitive expression of CD25 these cells can easily proliferate in response to 
IL-2 stimulation.  
In general, functional activity of NK cells is regulated by fine dynamic balance between the 
activating and inhibitory signals providing by the interaction of receptors and co-
stimulatory molecules with surface ligands of potential target cells, and depends also on the 
soluble factors produced by cellular environment [10, 11]. The density of interacting 
molecules on both effector and target cell surface is crucial for NK cell activity. Low or 
absence of inhibitory signals leads predominantly to NK cell activation through activating 
receptors followed by target cell lysis and cytokine release. On the other hand, high 
expression of activating ligands on target cells may trigger NK cell cytolytic activity, despite 
normal expression of MHC-I molecules [12]. The repertoire of activating and inhibitory 
receptors expressed on single NK cells is developed randomly during its maturation and 
differentiation [13]. The result of this expression is a diverse set of NK cell clones in the 
body. NK cells also express various adhesion and co-stimulatory molecules that participate 
in cell interaction and signaling. Diversity of NK cells allows them to identify damaged cells 
with distinct phenotypic characteristics and display functional response adapted to 
microenvironment.  
NK cells express multiple inhibitory and activating receptors regulating their cytolytic 
activity. Receptors of the KIR family recognize MHC-I molecules expressed by most normal 
cells in the body. Interaction of inhibitory ITIM-bearing KIRs with MHC-I results in 
abrogation of activation. MHC-I expression on the surface of virally infected and tumor cells 
have often been shown to decrease significantly, making these cells “invisible” to cytotoxic T 
lymphocyte recognition [14, 15]. In contrast, NK cells are able to recognize and lyse such 
cells due to diminished inhibitory signals. It is important to note that KIRs are able to 
distinguish between groups of MHC alleles. In the case of transplantation, graft cells with 
MHC-I molecules differing from the host proteins can be rejected by host NK cells. Various 
activating receptors for the most part serve to recognize cell surface molecules whose 
expression indicates viral infection, tumorigenesis or cell damage caused by cellular stress. 
Activating receptors of natural cytotoxicity receptor (NCR) family including  NKp46, 
NKp44 and NKp30 drive natural cytotoxicity against many tumor and virally infected cells 
upon signaling through linked ITAM-bearing CD3ζ, FcRγ, or DAP12 molecules [16, 17]. It is 
believed that these receptors have the ability to recognize molecules not expressed on the 
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surface of normal cells. In recent years, most of the ligands recognized by these receptors 
have been identified. NKp46 and NKp44 bind virus-derived hemagglutinins, and NKp30 is 
able to recognize human cytomegalovirus-encoded pp65 protein [18, 19]. The normally 
intracellular proteins vimentin and leukocyte antigen-B-associated transcript 3 (BAT3) are 
recognized by NKp46 and NKp30, respectively [20]. NKp30 binds a B7 family homolog (B7-
H6) expressed by some tumor but not normal cells [21]. A group of heparan sulfate/heparin 
molecules has been also proposed as ligands for NCR receptors [22]. Another important 
activating receptor NKG2D recognizes self-molecules which are usually absent or expressed 
on low level on the surface of normal cells but become expressed in tumor transformation, 
infection or in conditions of cell stress. A number of highly polymorphic “self” stress-
induced proteins such as MICA, MICB and a group of UL16 binding proteins (ULBPs) are 
ligands of NKG2D [23-25]. Appearance of these molecules on the cell surface serves for 
detection by NK cells of cell damaging alterations induced by oxidative stress, heat shock, 
hypoxia, genotoxic stress, virus infection or tumor transformation. 
Heat shock proteins (HSPs) represent another group of endogenous stress-induced proteins 
recognized by NK cells on the surface of target cells. HSPs, normally presented in cytoplasm, 
can be found on cell surface, in particular on the surface of tumor cells, virus-infected cells 
and cells subjected to stress. Tumor and stressed cells can also release HSPs in the 
extracellular milieu. It has been shown that expression of HSPs, in particular HSP70, on the 
surface of tumor cells increased cytotoxic activity of NK cells towards the targets. However, 
the activating receptors of NK cells for these molecules have not been identified. Membrane 
associated HSPs and their extracellular pool may constitute danger-associated molecular 
patterns (DAMPs) in the context of the “Danger model” proposed by P. Matzinger [26, 27]. 
Detection of stress-induced molecules as “danger signals” in conjunction with self MHC-I 
recognition by multiple sensor system possessed by NK cells underlies the complex process 
of NK cell activity regulation, although a full range of activating ligands recognized by NK 
cells still remains unknown. Reactive oxygen species (ROS) produced by activated monocytes 
and neutrophils also affect on NK cell functionality. ROS action leads to lowering of NKG2D 
and NKp46 expression by NK cells, that should decrease their cytolytic ability. Histamine 
was shown to prevent this effect of ROS on NK cells. Interesting, that CD56bright NK cells are 
more resistant to ROS action: NKG2D expression is unchanged on these cells [28, 29]. 
Simultaneous interactions of various surface molecules of target cells with NK cells lead to 
the integration of different intracellular signals, which together dictate the quality and 
intensity of effector NK cell response. Small changes in the target cell surface molecular 
profile may significantly influence the susceptibility of the cells to NK cell action. Cell stress 
induces multiple changes in protein synthesis and intracellular localization, and influences 
oligosaccharide expression. Intracellular perturbations caused by some types of cell stress 
might influence cell death and survival processes and are in close connection with the 
process of tumor cell transformation.  
Activity of NK cells may be influenced by both contact interactions with target cells and 
various soluble factors produced by surrounding cells under stress conditions, in particular 
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by extracellular pool of HSPs and MICA/B molecules. Besides stimulation of stress-induced 
protein expression, cell stress significantly modifies surface carbohydrate phenotype 
affecting NK cell effector functions. Membrane-associated oligosaccharides participate in 
NK cell – target cell interactions. Some of them have been identified to decrease NK cell 
cytolytic activity, others displayed stimulating effects on NK cells [30]. In this work we 
discuss our results obtained in the study of surface oligosaccharide influence on NK cell 
activation utilizing polymeric lipophilic neoglycoconjugates. We also present a study of 
involvement of surface and extracellular pools of HSP70 and MICA/B in regulation of 
human NK cells activity. The obtained results demonstrate that surface and soluble HSP70, 
as well as some fragments of this protein, activate NK cells in contrast to extracellular forms 
of MICA/B which inhibit cytotoxicity of NK cells. In addition, some characteristics of cell 
surface MICA/B expression in a model of ethanol-induced cell stress are discussed. 
2. Oligosaccharides in regulation of NK cell activity  
Oligosaccharides exposed on the plasma membrane of mammalian cells are an essential 
component of intercellular contacts inhibiting or cooperating with certain molecular 
interactions. Carbohydrate-carrying molecules also play a role in cell adhesion and signaling 
and contribute to immune cell activation or inhibition. Considerable changes in cell surface 
carbohydrate expression can be evoked by malignant transformation, infection or other 
unfavorable conditions and can be detected by NK cell recognizing system. Membrane-
associated glycans by their structural diversity might provide fine tuning of NK cell – target 
cell interactions and regulate NK cell activity. Positive and negative effects of various 
carbohydrate compounds including sialo-oligosaccharides, glycosphingolipids, complex 
and high mannose-type N-glycans, and others on NK cell-mediated effector functions have 
also been reported [31-33]. However only in rare cases ligand-receptor signaling pathways 
underlying the saccharide effects were identified. Recently, inhibitory receptor Siglec-7 
expressed by NK cells has been revealed to recognize specifically disaccharide Neu5Acα2-
8Neu5Ac [34]. It has therefore been suggested that the NK cell recognition of the sialic 
residues contributes to their tolerance to self-tissues. 
In our study we tested synthetic glycoconjugates designed to mimic the biological activities 
of native oligosaccharides for investigation of the effects of an array of oligosaccharides on 
NK cell activity. The lipophilic glycoconjugates were incorporated in target cells modifying 
carbohydrate phenotype of the plasma membrane, and NK cell cytotoxicity and cytokine 
production were assessed (Fig. 1).  
We found that glycoconjugates containing Lex, HSO3Lex and Ley structural motifs enhanced 
NK cell-mediated cytolysis of K562 cells as measured by analysis of NK cell-mediated 
caspase 6 activation in these cells (Fig. 2). The same oligosaccharides exposed on the cell 
surface displayed a potency to stimulate IFN-γ production with the strongest effect revealed 
for Ley-containing glycoconjugate. Only polymeric and not monomeric glycoconjugates 
displayed the abilities to increase NK cell activity. Lex antigen expressed as a part of 
glycoproteins and glycosphingolipids on many hematopoietic cells is mainly involved in 
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intercellular adhesion. Both Lex and Ley are also considered to be tumor-associated antigens 
[35]. Not all donors exhibited NK cell sensitivity to these glycoconjugates. This suggests a 
role for individual genetic polymorphism in glycan receptor expression, and also other 
mechanisms where the expression of molecules interacted with glycans might be regulated 
in the human organism throughout life. Polymeric glycoconjugates also had more biological 
activity than monomeric constructs in this system, suggesting that appropriate presentation 
is critical for carbohydrate recognition and subsequent biological effects. The unique mode 
of clustered oligosaccharide presentation provided by polymeric glycoconjugates may 
effectively mimic carbohydrate recognition found in nature. Most carbohydrate-lectin and 
carbohydrate-carbohydrate bonds require multivalent carbohydrate interactions for proper 
adhesion and signaling. The possible scenarios of carbohydrate-mediated interaction NK 
cells with target cells include the intercellular adhesion strengthening or/and the specific NK 
cell recognition of the saccharide determinants. Interestingly, only polymeric 
glycoconjugates presented on the cell surface in appropriate microenvironment affected NK 
cell activity. Glycoconjugates presented alone had no effect.  
 
Figure 1. Modification of K562 cells targeting by NK cells with polymeric glycoconjugates. 
 
Figure 2. Effects of glycoconjugates containing (A) Lex, (B) sulfated Lex or (C) Ley incorporated in target 
cell membrane on NK cell-mediated cytotoxicity.  
Thus, a proper presentation mode of the oligosaccharides was an essential requirement for 
biological effects of glycans connected with carbohydrate adhesion and cell recognition. 
Recently suggested model of a “glycosynapse” involves membrane assembly of different 
types of glycosylated molecules interacting with carbohydrate partners [36]. According to 
this model, oligosaccharide effects depend on their clustering and proper orientation of 
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“glycotopes”, and may result in a synergistic effect with protein-dependent interactions. 
Further investigations may discover additional physiological functions of glycans consisting 
of certain glycoproteins and glycolipids expressed in specific cell types. 
3. Surface and exogenous HSP70 in NK cell – Target cell interaction 
3.1. Involvement of membrane-associated HSP70 in NK cell – Target cell 
interaction 
As was mentioned above, stress-induced proteins exposed on surface of cells interacting 
with NK cells can be recognized by NK activating receptors followed by cytotoxic attack 
toward target cells. This fact highlights an important role of cell stress in the process of NK 
cell – target cell interaction. It is known that cellular stress response to any form of 
damaging factor results in a wide range of protective intracellular processes directed toward 
cell survival. Of critical importance among these counteracting cell reactions is the induction 
of high levels of HSP expression. HSPs are highly conserved and ubiquitously expressed 
proteins that are predominantly located in the cytoplasm and function as molecular 
chaperones [37]. However, evidence has now accumulated that translocation of HSPs to the 
cell surface may occur in stressed, infected and transformed cells [38-40]. Although 
mechanisms of translocation remain unclear, it seems plausible that surface HSPs may play 
a role as molecular markers of "altered" cells, destined to be eliminated by cytotoxic 
lymphocytes [39, 40]. Some tumors produce large amounts of HSPs that are expressed on 
the cell surface and can potentially attract NK cells [41, 42]. Surface expression of inducible 
form of HSP70 on human lung carcinoma cells was associated with their increased 
sensitivity to lysis by NK cells [43]. Also, IL-2 activated human NK cells were shown to 
recognize HSP70 on the surface of K562 erythroleukemia and human sarcoma cells 
subjected to heat shock [44-46]. Mechanisms by which surface HSPs may mediate 
recognition and elimination of tumor by cytotoxic lymphocytes remain poorly understood. 
One possibility is that immunogenic peptides expressed in association with HSP70 and 
HSP90 on tumor cells can be recognized by T lymphocytes, as well as NK cells [44, 48]. 
Another possibility is that HSPs themselves, e.g. HSP60 and HSP70 on the surface of tumor 
cells can be recognized by γδ-T cells in a non-MHC restricted manner [49]. Thus, the 
available evidence strongly suggests that surface HSPs, in particular HSP70, may be 
important in mediating recognition and/or elimination of tumor cells by host lymphocytes. 
Previously, we have shown that culture-adapted EL-4 mouse lymphoma lines express 
surface HSPs [37]. This fact was accounted for selection of EL-4 cell line in our in vitro mouse 
model aimed at investigation of a role of target cell surface HSP70 in tumor recognition and 
activation of cytotoxic effector cells. In this study we used EL-4 cells to analyze involvement 
of surface HSP70 of the target lymphoma cells in interaction with cytotoxic immune 
effectors. 
For these experiments C57BL/6 (H-2b), CBA (H-2k) and Balb/c (H-2d) mice were used. 
Cytotoxic effector cells were obtained from mouse spleen using standard methods [50]. The 
cytotoxic effectors were obtained either from intact mice or mice inoculated with  
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EL-4 lymphoma. In the latter case, C57BL/6 mice were inoculated intraperitoneally with 1x106 
EL-4 cells, and splenic effector cells were isolated 10 days after inoculation. Mouse EL-4 (H-
2b) lymphoma cells were maintained in vitro by passages in RPMI-1640 medium 
supplemented with 10% fetal calf serum (FCS), 4 mM L-glutamine, 20 mM HEPES, 10-5 M 2-
ME and 50 μg/ml gentamicin. For flow cytometric analysis FITC- or PE-conjugated anti-CD8, 
anti-CD4, anti-CD3, anti-γδTCR and anti-NK-1.1 mAb were used for cell staining. 
Fluorescent and laser scanning confocal microscopy was used to confirm surface localization 
of HSP70 in EL-4 cells stained with anti-HSP70 antibody (clone BRM22). MTT- and LDH 
viability assays [51, 52] were applied to evaluate cytotoxic effect of the effectors in the in vitro 
models. To determine whether expression of MHC class I molecules and HSP70 on the 
surface of EL-4 cells plays a role in cytotoxic response against these targets, we performed 
antibody blocking assay using following mAb: anti-MHC class I (clones HB11 and HB51), 
anti-HSP70 (clone BRM22), or anti-Thy-1.2, as a control (clone 53-2). To remove CD8+ 
cytotoxic T lymphocytes from the effector cell population a magnetic bead separation method 
was used (Dynal, Germany). 
At the first stage of the study the surface localization of HSP70 on EL-4 cells registered 
previously by flow cytometry was confirmed with confocal microscopy (Fig. 3). 
Splenic effector cells from normal C57BL/6 mice demonstrated strong cytotoxicity against 
EL-4 cells. By MTT assay, after 6 h incubation of EL-4 with effector cells, percent cytotoxicity 
ranged from 6 ± 1% to 28 ± 3%, at E:T ratios 5 and 20, respectively. Similar levels were 
detected by LDH release assay (Fig. 4A), thus confirming the validity of the MTT method. 
After 24 h incubation, cytotoxicity increased up to 18 ± 2% and 61 ± 15%, at E:T ratios 5 and 
20, respectively (Fig. 4A). Effector cells from allogeneic mice (CBA and Balb/c) demonstrated 
similar levels of cytotoxicity against EL-4 cells (data not shown). Splenic effector cells from 
C57BL/6 mice inoculated with EL-4 cells 10 days prior to the experiment, showed negligible 
cytotoxicity after 6 h incubation. However, they exhibited a pronounced cytotoxic effect 
against EL-4 cells after 24 h of incubation with the targets (Fig. 4B). 
To determine whether surface expression of HSP70 on EL-4 cells is important for their 
recognition and elimination by cytotoxic lymphocytes, we first incubated EL-4 cells with 
anti-HSP70 antibody and then used these cells as targets in a 6 hour cytotoxicity assay. 
Splenic effector cells from normal C57BL/6 mice showed markedly decreased cytotoxicity 
against target EL-4 cells pretreated with anti-HSP70 mAb (Fig. 5A). Inhibitory effect of the 
antibody was also observed in allogeneic co-culture, i.e. with effector cells from CBA (Fig. 
5C) and Balb/C mice (data not shown). Similar result was obtained using splenic effector 
cells from C57BL/6 mice inoculated with EL-4 tumor: percent cytotoxicity 21 ± 5% (target 
EL-4 cells pretreated with anti-HSP70 antibody) versus 53 ± 11% (untreated EL-4 cells), at 
E:T ratio 20 and 24 h incubation. In contrast, pretreatment of target EL-4 cells with anti-H-
2b antibody resulted in their enhanced killing by syngeneic effector cells (Fig. 5B). A 
control anti-Thy1.2 antibody was without effect (Fig. 5D). It should be mentioned that 
treatment with antibodies alone (anti-H-2b, anti-HSP70) for up to 24 h, did not affect 
viability of either target EL-4 cells or splenic effector cells (data not shown). 
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Figure 3. Visualization of cell surface expression of HSP70 in in vitro cultures of EL-4 cells performed by 
using fluorescent (A) and laser scanning confocal (B) microscopy (images were recorded using a Nikon 
TE-2000 confocal microscope; excitation was at 488 nm argon-ion laser) ; fluorescence emission was 
detected in the 500-550 nm for Alexa Fluor 488.  Cells were imaged in a Z-stack and both sections and 
the reconstructed images examined for HSP localization. These images clearly demonstrate the cell 
surface localization of HSP70. 
Next, we addressed the question of whether killing of EL-4 cells in our model was mediated 
by NK cells or cytotoxic T lymphocytes. To this end, we depleted CD8+ cells from the splenic 
effector cell population obtained from intact C57BL/6 mice. Typically, effector cell 
population contained 5% sIg+, 36% CD8+, 48% CD4+, 88% CD3+, 2% γδTCR+, and 10% NK1.1+ 
cells. After depletion of CD8+ cells, the population contained 7% sIg+, 60% CD4+, 57% CD3+, 
3% γδTCR+, and 25% NK1.1+ cells. Thus, it was relatively enriched for NK cells. As is shown 
in Fig. 6, cytotoxicity against EL-4 cells increased, rather than decreased, after depletion of 
CD8+ cells from the effector cell population. Moreover, cytotoxicity was significantly  
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Figure 4. Cytotoxicity of C57BL/6 splenic effector cells after 6 and 24 h of incubation with the target EL-
4 cells measured by MTT and LDH assays. (A) Cytotoxic effector cells were isolated from spleens of 
intact mice. (B) Cytotoxic effector cells were isolated from spleens of mice inoculated with EL-4 cells 10 
days prior to experiment. Results are the mean of triplicate cultures ±S.E.M. 
 
 
Figure 5. The effect of treatment of EL-4 target cells with antibodies to HSP70, MHC class I molecules 
and Thy1.2 on their sensitivity to killing by splenic effector cells. Cytotoxic effector cells were isolated 
from syngeneic C57BL/6 mice (A, B, and D) or allogeneic CBA mice (C). Results are the mean of 
triplicate cultures ±S.E.M. 
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inhibited by pretreatment of target EL-4 cells with anti-HSP70 mAb. Hence, lysis of EL-4 
cells in this system seems to be predominantly mediated by CD8ˉ cells, possibly NK cells, 
and may involve recognition of surface HSP70 present on EL-4 target cells. 
 
Figure 6. The effect of depletion of CD8+ cells from splenic effector cell population obtained from intact 
C57BL/6 mice on cytotoxicity against EL-4 target cells, treated or untreated with anti-HSP70 antibody. 
Results are the mean of triplicate cultures ±S.E.M. 
3.2. Exogenous HSP70 as mediators of NK cell activation 
As stated above HSPs are intracellular proteins functioning as molecular chaperones; at the 
same time evidence has now accumulated that HSPs can localize on cell surface and can exit 
to the extracellular space, including blood. These two forms of HSPs – membrane-associated 
and extracellular soluble proteins – have immunomodulatory capabilities realizing by 
different mechanisms. Translocation of HSPs to plasma membrane has been observed in 
stressed, infected and transformed cells. It seems plausible that surface HSPs may represent 
molecular targets for recognition and elimination of ‘altered’ cells by cytotoxic lymphocytes, 
in particular NK cells. In this report we describe some models enabling to study 
mechanisms of interaction of NK cells with the target tumor cells bearing HSP70 on their 
surface. 
Extracellular HSPs act as soluble immunostimulators affecting different immune cells such 
as DCs, macrophages, T and NK cells. HSPs can bind extracellular peptides from dead cells. 
Such HSP-peptide complexes become internalized by professional antigen-presenting cells – 
DCs or macrophages – where peptides release from complexes with HSP and become 
reassociated with MHC molecules. This process is called “cross-presentation”; HSPs act here 
as extracellular chaperones able to bind peptides of different structure [53-55]. On the other 
hand HSPs can also directly stimulate immune cells. For example, HSP70 added to DCs and 
macrophages induces their maturation and cytokine secretion. Exogenous HSP70 also 
stimulates proliferation and cytotoxicity of human NK cells, moreover, NK cells were shown 
to move by the gradient of HSP70 concentration [56, 57]. Thus, HSPs can act on immune 
cells similar to cytokines or chemokines. Due to such dualism extracellular HSPs were 
named “chaperokines”, i.e. chaperones plus cytokines [58]. 
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To clearly elucidate any immunostimulatory action of HSP70 on NK cells, we tested 
whether exogenous HSP70 influences NK cell cytokine secretion. In our experiments we 
analyzed effects of HSP70 on IFN-γ production by human NK cells. NK cells were isolated 
from peripheral blood samples by centrifugation on Ficoll density gradient with subsequent 
magnetic separation of mononuclear cell population using MACS NK cell isolation kit 
(Miltenyi Biotec, Germany) or cell sorting using fluorescent labeled CD3, CD16 and CD56 
antibodies. Recombinant human HSP70 expressed in E.coli (#NSP-555, Stressgen, Canada) 
was used in experiments. HSP70 was added to isolated NK cells without or with 500 U/ml 
IL-2 (Hoffmann-La-Roche, Switzerland). After incubation for 18 h in 37oC, 5% CO2, 
supernatants were collected and analyzed for IFN-γ content using Human IFN-γ ELISA kit 
(Pierce Endogen, USA). Effect of HSP70 on IFN-γ production by NK cells was also analyzed 
by flow cytometry. NK cells incubated with HSP70 and IL-2 were collected and fixed by 
paraformaldehyde. Cells were then labeled intracellularly with fluorescent conjugated 
antibody to human IFN-γ (BD Pharmingen, USA). Samples were then analyzed by flow 
cytometry (BD FACScan, BD Biosciences, San Jose, CA USA) and the percentage of NK cells 
producing IFN-γ was measured. 
 
Figure 7. Recombinant human HSP70 stimulated IFN-γ production in NK cells activated by IL-2. IFN-γ 
production was measured by ELISA. Similar results were obtained with intracellular IFN-γ 
measurement by flow cytometry (data not shown).   
HSP70 in dose 5 μg/ml did not induce IFN-γ production in native NK cells (Fig. 7). 
However HSP70, when added together with IL-2, did markedly stimulate it. Similar data 
were obtained with intracellular staining of NK cells. Thus HSP70 was shown to stimulate 
cytokine production in IL-2 activated NK cells. This fact is very consistent with the assumed 
role of HSPs as danger-associated molecular patterns (DAMPs) able to activate a range of 
cellular mediators of innate immunity. It seems HSP70 exerts a cytokine-like action on NK 
cells; however, it does not work by itself.  It needs in initial activation by cytokines like IL-2 
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(similar results were obtained using IL-12 and IL-15, data not shown). It is important to note 
that no receptors for HSP70 on NK cells were found. Based on presented data we can 
speculate about a putative HSP70 receptor which expression is triggered under cytokine-
mediated NK cell activation. There is also a possibility that some NK cell subpopulations are 
more sensitive to HSP70 action. To test this we investigated whether HSP70 induced IFN-γ 
production in sorted CD56bright and CD56dim human NK cells. 
Cell sorting of CD3–CD16–CD56+ and CD3–CD16+CD56+ NK cells was performed on a 
fluorescence-activated cell sorter (FACSVantage DiVa, BD Biosciences, USA), with final 
purities at 99%. HSP70 was added to sorted NK cells simultaneously with IL-2 (600 U/ml). 
After 18 h incubation supernatants were collected and analyzed by ELISA as described 
above.  
 
Figure 8. Effect of HSP70 on IFN-γ production of two major NK cell subpopulations. (A) Flow 
cytometric analysis of sorted NK cell subpopulations. (B) Recombinant human HSP70 stimulates IFN-γ 
production in both NK cell subpopulations CD16–CD56+ and CD16+CD56+ in presence of IL-2 (600 
U/ml). 
HSP70 enhanced IFN-γ production in both NK cell subpopulations (Fig. 8), and CD16–
CD56+ cells produced larger amount of that cytokine. It is known CD56bright NK cells 
produce markedly higher amount of cytokines than CD56dim. So, possibly the higher effect 
of HSP70 on CD56bright cells was due to properties of this NK cell subpopulation. 
The next step of our work was the elucidation of HSP70 fragments which are responsible for 
apparent effects of that protein. Previously Botzler and coworkers demonstrated that 
substrate-binding domain of HSP70 is responsible for stimulating HSP70 effect on NK cells 
[44]. Then they had shown NK cells could be activated by a 14 aa fragment of HSP70 with 
sequence TKDNNLLGRFELSG. This fragment named TKD-peptide corresponds to 450-463 
aa residues belonging to substrate-binding domain of HSP70 [59].  
Using a special in silico approach we analyzed five peptide fragments belonging to 
substrate-binding domain in comparison with TKD-peptide for their ability to activate NK 
B A 
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cells. The method of analysis of informational structure (ANIS) proposed by A.N. Nekrasov 
[60, 61] was used for search of potentially active fragments of HSP70 sequence. Five 
peptides were chosen and synthesized (Fig. 9). All of them were tested for ability to induce 
IFN-γ production in human NK cells isolated from peripheral blood by magnetic 
separation. Peptides were added to NK cells together with IL-2 in concentration 2 μg/ml. 
Cells were incubated for 18 h and then intracellular staining with antibody to IFN-γ was 
performed as described above.  
Most peptides including TKD-peptide developed by G. Multhoff did not significantly 
enhance the amount of IFN-γ producing cells. Only peptide comprising residues 526-543 of 
HSP70 (P2) markedly induced IFN-γ production. Its effect was even greater than HSP70 
full-length protein. It can be explained by difference in molar concentrations: 2 μg/ml 
solution of such peptide corresponds to the greater molar concentration than 5 μg/ml 
solution of HSP70 protein. Similar data were obtained from experiments with cytotoxicity of 
NK cells against K562 target cells measured using assay for caspase 6 activity 
(Oncoimmunin, USA). Only P2 peptide significantly stimulated lysis of K562 by NK cells. 
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Figure 9. Testing of HSP70 peptide fragments for an ability to stimulate IFN-γ production in NK cells. 
Peptides were added in concentration 2 μg/ml. Amount of IFN-γ producing NK cells was determined 
by flow cytometry using intracellular staining with anti-IFN-γ antibody. Testing of the peptides in 
cytotoxicity assay provided similar results (data not shown).  
In human peripheral blood there are many cells which have shown to be activated by heat 
shock proteins, including monocytes and blood DCs. Even small numbers of such cells can 
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exert an influence on the apparent effect of HSP70 on NK cells. We therefore analyzed 
whether the presence of additional cell populations in NK cell preparations can affect HSP70 
induced IFN-γ production. For that purpose NK cells and DCs were isolated by fluorescence 
activated cell sorting.  PBMCs were stained with antibodies CD3-TC, CD11c-APC (Caltag, 
USA), CD16-FITC and CD56-PE (Beckman Coulter, USA). PBMCs were sorted into CD3–
CD11c–CD16+CD56+ (NK cell) and CD3–CD11c+CD16–CD56– (myeloid DC) fractions using 
FACSVantage DiVa. Purity was 97-98%. NK cells were then mixed with DCs in different 
proportions in presence of suboptimal dose of IL-2 (300 U/ml) and HSP70 was added. After 
18 h incubation supernatants were collected and analyzed for IFN-γ content by ELISA 
(Pierce Endogen, USA). 
Low doses of IL-2 did not markedly induce IFN-γ production (Fig. 10A). Mixtures of NK 
cells with DCs produced larger amounts of IFN-γ proportional to the numbers of DCs. This 
is fully consistent with current view on NK-DC interactions. It seems that DCs in the 
mixture with NK cells provided a stimulating signal which is additional to suboptimal dose 
of IL-2. Effect of HSP70 was more noticeable if it was added to the cell mixtures and 
increased proportionally to the elevation of basal level of IL-2 induced IFN-γ production. 
Thus, the amount of DCs in NK cell preparations was very important factor affecting NK 
cell functions, though in our experimental conditions DCs did not influence HSP70-
mediated induction of NK cell activation. 
Other important problem linked to HSP70 physiological action is its potential association 
with bacterial lipopolysaccharides (LPS).  LPS can activate a range of cells of immune 
system via Toll-like receptor 4 (TLR4) [62]. Many reports describe LPS contamination 
causing apparent HSP effects on different immune cells [63-65]. HSP70 protein used in our 
experiments was recombinant, expressed in E.coli, so we might assume it was contaminated 
by LPS. To investigate it we have performed amoebocyte Limulus lysate (LAL) assays for 
LPS activity in HSP70 samples  (E-Toxate kit, Sigma-Aldrich, USA). HSP70 samples were 
shown to contain more than 10000 U/mg of LPS. Thus, additional experiments were 
necessary to investigate the role of LPS in NK cell activation. NK cells isolated by magnetic 
separation were incubated with LPS, HSP70 known to be LPS-negative ((#ESP-555, 
Stressgen, Canada) and IL-2 for 18 h. Cells were collected, fixed and stained with fluorescent 
labeled antibody to human IFN-γ (BD Pharmingen, USA). 
As with HSP70, LPS did not markedly stimulate IFN-γ production in native NK cells (Fig. 
10B). However it did lead to a significant increase of IFN-γ producing cells then added 
together with IL-2. Thus, LPS stimulated NK cells only in cooperation with IL-2. 
Interestingly, HSP70 purified from LPS (HSP70 low endotoxin, HSP70-LE) added together 
with IL-2 did not stimulate IFN-γ production in contrast to non-purified protein. 
Moreover, HSP70-LE added together with LPS inhibited LPS-induced IFN-γ production 
showing effect opposite to LPS. One explanation for the inhibitory effect of HSP70-LE is 
that LPS and HSP70 compete for the same receptors on the cell surface. However it does 
not explain the activating effects of p6 and TKD peptides on NK cells. Additional 
experiments are required to characterize the regulatory role of exogenous HSP70 in NK cell 
functioning.  
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Figure 10. (A) Admixture of blood DCs affects IFN-γ production by NK cells. DCs and NK cells were 
isolated by cell sorting and mixed in different proportions with IL-2 in suboptimal dose, HSP70 was 
added. IFN-γ concentration in supernatants was analyzed by ELISA. (B) LPS stimulates IFN-γ 
production by NK cells in presence of IL-2. LPS, IL-2 and HSP70-LE were added to isolated NK cells, 
amount of IFN-γ producing NK cells was determined by flow cytometry using intracellular staining 
with anti-IFN-γ antibody. 
Thus, multiple data support that activity of NK cells can be modulated by HSP70 both 
bound to the target cell surface and extracellular soluble HSP70. However, exact 
mechanisms of HSP70 reception by NK cells and HSP70-induced signaling are still not 
known. Moreover, a role of LPS in NK cell activation remains to be investigated. 
4. Role of proteins MICA/B in regulation of NK cell activity 
Another type of stress-induced proteins that play an important role in NK cell regulation is 
represented by molecules reacting with the activating receptor NKG2D. NKG2D is 
expressed by most NK cells; it recognizes two groups of ligands – ULBPs and MIC proteins 
distinct by structure and membrane anchoring [23, 25]. MICA and MICB, the most 
extensively studied NKG2D ligands, are highly glycosylated transmembrane proteins with 
one site of S-acylation necessary for anchoring in plasma membrane. They share high 
homology with MHC-I but are not associated with β2-microglobulin and do not bind 
antigenic peptide. Like MHC-I, they consist of three extracellular domains (α1, α2 and α3), 
A 
B 
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with two of them, α1 and α2, forming a site for NKG2D binding [66]. Oppositely, ULBPs 
have less homology with MHC-I molecules. They have neither an extracellular α3-domain 
nor a transmembrane domain, anchoring to the plasma membrane through GPI. This feature 
determines constitutive localization of ULBPs in lipid rafts of the plasma membrane [25, 67]. 
MIC proteins in their turn are also found in lipid rafts, however, their physical link to these 
membrane domains is less tight: they are able to transfer between rafts and the detergent-
sensitive, “usual” bilipid zone [67].  
Previous data demonstrates that in humans the MICA-NKG2D pair participates in 
regulatory interactions between NK cells and other cells involving in immune response. 
Interactions of membrane bound MICA/B with NKG2D lead to activation of NK cells and 
elimination of aberrant cells. MICA/B proteins exposed on the cell surface serve as a 
“danger signal” for cytotoxic lymphocytes and mark the cells that should be eliminated  
(Fig. 11).  
 
Figure 11. Receptor NKG2D recognizes proteins MICA/B. NK cells and K562 target cells were labeled 
with anti-NKG2D-Alexa Fluor 488 antibody and primary anti-MICA/B and secondary antibody 
conjugated with Alexa Fluor 555, respectively. 
In our experiments we found a role for MICA/B in NK cell-mediated cytotoxicity using both 
intact human NK cells and cells of NK-cell-like line NKL. NK cells were isolated from 
human peripheral mononuclears by magnetic separation. Cytotoxicity was measured by 
flow cytometry method based on estimation of caspase 6 activity in target cells. Antibodies 
against both NKG2D and MICA/B significantly inhibited cytotoxic activity of effector cells 
against erythroleukemia cell line K562 and B-lymphocytic cell line 721 (Fig. 12). The values 
of cytotoxicity and levels of the inhibition varied for different target cell lines not depending 
directly on MICA/B expression. The results suggested that NKG2D-MICA/B interactions 
were not the only way of NK cell recognition of these target cells. Expression of NKG2D and 
cytotoxic activity of NK cells increased remarkably following their incubation with IL-2. 
Finding ways of additional induction of surface expression of MICA/B on the cell surface 
might be useful for developing new approaches for increase of tumor cell sensitivity to 
cytotoxic lymphocyte action. 
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Figure 12. Cytolytic action of NK cells is mediated by NKG2D-MICA interaction. (A) Measurement of 
cytotoxicity of NK cells against K562 and 721 target cells in presence of antibody to NKG2D.  
(B) Measurement of cytotoxicity of NKL cells against 721 target cells in presence of antibody to NKG2D.  
(C) Cytotoxicity of NK cells against K562 cells treated with antibody to MICA. 
MIC proteins can be released from the cell surface into the extracellular space. At least two 
pathways of release were documented: proteolytic shedding of extracellular part of MIC 
molecule and formation of exosomes containing MICA/B [68, 69]. Both mechanisms result in 
accumulation of soluble form of MIC (sMIC) in the extracellular space. Proteolytically 
cleaved sMICA/B circulate in human blood and can be found at remarkable levels in sera of 
tumor patients. This type of sMIC is also generated during viral infections. In contrast to 
membrane-associated MIC proteins, circulating forms of MICA/B are able to inhibit 
activation of NK cells and lead to anergy. It is hypothesized that tumor cells can use this 
mechanism to evade immune surveillance [25]. Proteolysis of MIC proteins occurs by a 
number of metalloproteinases, at least three of them were recently identified: two proteins 
of ADAM (A Disintegrin And Metalloproteinase) family, ADAM10 and ADAM17, and 
matrix metalloproteinase MMP14 [70, 71]. Metalloproteinases cleave MICA in a linker 
sequence between the transmembrane domain and the α3 domain. There is no definite site 
of hydrolysis, but sufficient length of the linker region is essential [72]. MICA is expressed 
on the cell surface in complex with proteins originally found in endoplasmic reticulum (ER): 
ERp5, GRP78, and two proteins of 47 and 48 kDa of thioredoxin family. ERp5 reduces a 
unique disulfide bond in α3 domain of MICA and induces conformation changes of the 
domain rendering the MICA molecule accessible for metalloproteinases. The roles of GRP78 
and two other proteins associated with MICA on cell surface in sMICA shedding remain to 
be elucidated [73]. 
We estimated the amounts of sMIC in peripheral blood sera of patients with 
lymphoproliferative diseases.  Levels of sMIC were measured in seven groups of patients 
with different types of lymphoproliferative diseases consisted of from 5 to 20 patients in a 
group (Fig. 13). sMICA/B concentrations were measured by ELISA (R&D Systems). The 
analysis of the data in every group was performed using a nonparametric Mann-Whitney 
test. The mean value of sMIC in the control group equaled 40 pg/ml and was not greater 
than 250 pg/ml. In all studied groups with the exception of Burkitt-like lymphoma group the 
mean sMIC serum levels exceeded significantly the levels in the group of normal donors. 
The highest levels of sMIC content were found in patients with T-cell anaplastic 
lymphomas. 
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Figure 13. sMICA/B content determined in sera of patient with lymphoproliferative diseases.  
1 – healthy donors, 2 – chronic lymphocytic leukemia, 3 – diffuse large B-cell lymphoma, 4 – lymphatic 
plasmacytoma, 5 – follicular lymphoma, 6 – T-cell anaplastic lymphoma, 7 – Burkitt-like lymphoma,  
8 – lymphocytoma. 
4.1. MICA/B expression under ethanol-induced cell stress conditions  
The mechanisms of MICA/B regulation are still not completely clear. Expression of MICA/B 
genes on the mRNA level is found in virtually all tissues of the organism. However 
considerable constitutive expression of membrane-associated proteins was detected only on 
intestine epithelial cells [74]. It is suggested that MIC proteins participate in maintaining the 
integrity of the gut epithelium promoting NKG2D-dependent recognition and prompt 
elimination of damaged epithelial cells by intraepithelial lymphocytes [75]. There are evidence 
that some cellular miRNA can impair translation of mRNAMICA/B, setting up a threshold for 
MICA/B expression. In stress conditions as well as in cell transformation, viral infection and 
surgical procedures including transplantation, MIC gene transcription markedly increased, 
specific miRNA was degraded and MIC proteins appeared on the cell surface [76, 77]. 
Transcription factors NFκB, Sp1, Sp3 were shown to stimulate MIC surface expression. MIC 
expression induced by heat shock is dependent on HSF1 binding to heat shock response 
element (HSRE) located in promoter region of MIC genes [25]. Genotoxic stress causes MIC 
surface expression via ATM/ATR kinases, sensors of DNA damages, triggering signaling 
cascade which leads to cell cycle arrest, induction of DNA reparation and expression of NKG2D 
ligands [78]. In many cases mechanisms of MIC expression triggering remain unclear. 
In our work we produced a reliable model of induction of MICA/B surface expression based 
on cell treatment with ethanol. Using this model we analyzed MICA/B expression in 
transcriptional, surface and extracellular levels of MICA expression.  
It is well known that ethanol can exert damaging effects on many types of cells. It influences 
membrane fluidity and induces oxidative stress in cells [79]. Ethanol can also affect immune 
response, particularly by triggering apoptosis in lymphoid and myeloid cells [80]. All these 
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data characterize ethanol as a good inductor of cell stress conditions. We applied ethanol to 
induce cell stress in a range of hemopoietic cell lines in order to analyze its influence on 
MICA/B expression. Surface MIC expression was analyzed by flow cytometry (FACScan, BD 
Biosciences) and confocal microscopy (Nikon TE-2000 confocal microscope). Monoclonal 
antibodies to MICA/B (R&D Systems) were used for protein visualization. Expression of 
MICA/B genes was registered by RT-PCR. Percentages of apoptotic and necrotic cells were 
measured by cell staining with fluorescent-labeled annexin V and propidium iodide using 
flow cytometry. Soluble MICA/B forms were detected by ELISA. 
For the study we chose several human hemopoietic cell lines of different origin: acute T cell 
leukemia Jurkat, erythroblastoid leukemia K562, monocytic leukemia THP-1 and melanoma 
cell line MelJuSo. The cell line C1R-MICA transfected with MICA gene was used as a 
positive control. The cell lines differed in spontaneous MICA/B surface expression (Fig. 14). 
The maximal MICA/B expression comparable with expression in C1R-MICA was registered 
in THP-1 cells. Even those cells, which had no spontaneous MICA/B expression on the cell 
surface had high levels of mRNAMIC (data not shown). 
 
Figure 14. Spontaneous MICA/B surface expression in different hemopoietic  tumor cell lines: K562 – 
human erythroblastoid leukemia, Jurkat – human T cell leukemia, THP-1 – human acute monocytic 
leukemia, MelJuSo - human melanoma , C1R-MICA – transfected cells (positive control).  
We found that treatment of cells with ethanol modulated MICA/B cell expression. Short term 
cell treatment with ethanol (1 h) leaded to partial elimination of MICA/B from the cell 
surface. In the same time incubation of cells in the presence of ethanol in concentration range 
0.25-3% for 18 h resulted in increased expression of MICA/B on the cell surface (Fig. 15). 
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Ethanol at high concentrations resulted in a reduction of MICA/B surface expression and an 
elevation of apoptosis and necrosis in cell culture (Fig. 16). Ethanol-induced increase of 
MICA/B surface expression preceded cell death caused by higher ethanol concentration. We 
can assume that the exposure of MICA/B proteins on the cell surface under cell stress 
conditions allows cytotoxic lymphocytes expressing receptor NKG2D to identify stressed 
cells in which the program of cell death has not yet been activated. 
We also checked expression of MICA/B at the mRNA level in the hemopoietic cell lines and 
normal human leukocytes. mRNAMICA/B was easily detected in all cells tested without cell 
stress conditions. Increase of mRNAMICA/B level in cells was registered at 3 h of ethanol 
treatment (Fig. 17). One of the mechanisms of damaging effects of ethanol on cells is the 
induction of oxidative stress in cells that can cause DNA damage. We found out that 
ethanol-induced MICA/B upregulation did not depend on ATM/ATR kinase activity, 
suggesting that genotoxic effects were not the mechanism of this process (data not shown).  
 
Figure 15. MICA/B surface expression alterations in Jurkat cells followed ethanol treatment for 18 
hours. Incubation of cells (5x105 cells/ml) was performed in RPMI medium containing 10% FCS. 
Images were collected with a Nikon TE-2000 confocal microscope equipped with 405, 488 and 543 
nm lasers and standard set of detectors. A. MICA/B surface expression measured by flow 
cytometry. Cells were labeled with primary MICA/B antibody and secondary antibody conjugated 
with AlexaFluor488. Nuclei were identified with Hoechst 33342. MICA/B expression levels were 
calculated as ((exp/2аb)-1)*100%, where exp – mean of fluorescence intensity of experimental 
sample, 2ab – mean of fluorescence intensity of control sample labeled only with secondary 
antibody. B – MICA/B surface expression after ethanol treatment analyzed by confocal microscopy. 
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Another mechanism of MICA/B surface expression increase under ethanol action was 
revealed in K562 cells. With confocal microscopy, it was shown that under the influence of 
ethanol-induced cellular stress the inner pool of MICA/B decreased and the surface pool 
increased as compared with the control cells indicating that under the alcohol influence 
MICA/B moved from the cytoplasm to the cell surface (Fig. 18). 
Thus, ethanol affects MICA/B expression in cells at several levels resulting in induction of 
MICA/B de novo expression, translocation of intracellular protein pool to the cell surface 
and release of MICA/B proteins from the cells. MICA/B exposure on the cell surfaces and 
shedding of these proteins with formation of the extracellular pool are the latest stages of 
MICA/B cell expression. Both surface and extracellular forms of MICA/B proteins may 
take part in immune regulation acting on NKG2D-expressing cytotoxic lymphocytes.  
 
 
 
 
Figure 16. Ethanol influence on cell viability of THP-1 cells. A - Percentage of apoptotic cells in cell 
culture treated with ethanol for 18 h. B - Percentage of necrotic cells in cell culture treated with ethanol 
for 18 h. C - Flow cytometry analysis of MICA/B surface expression. THP-1 cells were stained with anti-
MICA/B antibodies with FITC-labeled secondary antibodies, Alexa Fluor 647-labeled annexin V and 
propidium iodide.  
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Figure 17. mRNAMICA/B expression estimated by RT-PCR in different kinds of cells. A. mRNAMICA/B 
expression in human T cells and monocytes. B. mRNAMICA/B expression in Jurkat cells subjected to 
ethanol treatment. 
 
Figure 18. Intracellular and surface pool of MICA/B proteins in control K562 cells and the cells after 
ethanol treatment. MICA/B expression was detected with secondary antibodies labeled with Alexa 
Fluor 488 and Alexa Fluor 568 for surface and intracellular proteins, respectively.  Images were 
recorded with Nikon TE-2000 confocal microscope equipped with 405, 488 and 543 nm lasers and filters 
appropriate for Alexa Fluor 488, Alexa Fluor 568 and Hoechst 33342. 
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5. Conclusion 
These experiments confirmed an important role of stress-induced modification of target 
cell surface for the process of NK cell – tumor cell interaction. Our data showed that this 
interaction is modulated by both alteration of cancer cell surface molecular pattern 
(including surface oligosaccharide profile) and extracellular pool of stress-induced 
proteins released by the target cells. Noteworthily, our results show that surface and 
soluble HSP70 activate cytolytic NK activity in contrast to extracellular form of MICA/B 
which inhibits cytotoxicity of NK cells. We hypothesize that stress-induced HSP70 and 
MICA/B protect target cells from NK-mediated effects on two levels: HSP70 serves as 
protective molecule for key cell components (in the cell space) and MICA/B provide a 
distant resistance inhibiting NK cell cytotoxic activity before the interaction with a 
target. 
An important point of the obtained results is connected with HSP70 fragments identified by 
a special in silico approach. Testing of synthetic analogs of the fragments demonstrated in 
our models an essential activity of some peptides, similar to the effect of whole molecule. 
This data has important implications for future application of stress-induced proteins in 
cancer diagnostic and therapy. 
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